Envision Pharma Group has hired clinical research veteran Nick Jones as president of its Envision Medical Communications (EMC) business.
Mr. Jones will lead the company’s EMC division, which works with biopharmaceutical and medical technology companies across areas such as medical affairs, commercialization and market access. According to an April 8 release, Jones’ primary focus will be on integrating Envision’s technology and AI capabilities into the company’s portfolio of solutions and services.
He has a deep background in clinical research, including serving as SVP and GM of commercial solutions at ConcertAI, as well as more than 10 years at CRO and consulting firm IQVIA.
“Nick brings deep expertise, global market insight and a shared ambition to build a world-class, technology-enabled pharmaceutical services organization,” said Tom Langan, CEO of Envision Pharma Group. “His extensive experience in technology and consulting will benefit both Envision and our clients. This is another step in our evolution as we strive to execute with precision and exceed our clients’ expectations.”
